Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BUD
BUD logo

BUD Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
75.610
Open
75.530
VWAP
75.39
Vol
125.53K
Mkt Cap
147.79B
Low
75.260
Amount
9.46M
EV/EBITDA(TTM)
10.54
Total Shares
1.95B
EV
224.91B
EV/OCF(TTM)
--
P/S(TTM)
2.61
Anheuser-Busch Inbev SA is a Belgium-based company. The Company is primarily engaged in the manufacturing of beer. The Company operates through six segments: North America, Middle Americas, South America, EMEA, Asia Pacific, Global Export and Holding companies. The Company's brand portfolio includes global brands, such as Budweiser, Corona and Stella Artois; international brands, including Beck's, Leffe and Hoegaarden, and local champions, such as Bud Light, Skol, Brahma, Antarctica, Quilmes, Victoria, Modelo Especial, Michelob Ultra, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske, Cass and Jupiler. The Company's soft drinks business consists of both own production and agreements with PepsiCo related to bottling and distribution arrangements between its various subsidiaries and PepsiCo. Ambev, which is a subsidiary of the Company, is a PepsiCo bottler. Brands that are distributed under these agreements are Pepsi, 7UP and Gatorade.
Show More

Events Timeline

(ET)
2026-02-12
09:00:00
Futures Modestly Higher, S&P 500 Futures Up 0.42%
select
2026-02-12
05:30:00
Company Sees FY26 Capital Expenditures of $3.5B to $4B
select
2026-02-12
05:30:00
AB InBev Reports Q4 Revenue of $15.56B
select

News

CNBC
6.5
04-16CNBC
Apollo CEO Defends Private Credit Amid Market Scrutiny
  • Redemption Policy: Apollo Global Management has set a 5% quarterly redemption limit in its private credit fund, despite other firms relaxing their limits, aiming to maintain liquidity and bolster investor confidence, even as it faces redemption requests representing 11% of its assets.
  • Market Risk Assessment: CEO Marc Rowan stated that software sector valuations are generally overstated, particularly in the context of rapid AI advancements, emphasizing the need for investors to have a clear understanding of their holdings to avoid potential risks and losses.
  • Investment Scale and Returns: Last year, Apollo originated $310 billion in new investments, with 80% being investment-grade financing, serving major clients like Intel, BP, and Shell, indicating a robust investment strategy in a high-risk market.
  • Role of Tech Companies in Debt Market: Rowan noted that the influence of technology companies in the debt market will continue to grow, predicting that in the next five years, major issuers of investment-grade debt will be dominated by large tech firms and banks, reflecting significant structural changes in the market.
Fool
8.5
04-08Fool
Sysco and McCormick Announce Major Acquisitions
  • Sysco Acquisition Update: Sysco is acquiring Restaurant Depot for $26 billion, aiming to enhance its supply chain efficiency across 700,000 restaurants, although it faces potential antitrust scrutiny that could complicate the deal.
  • McCormick and Unilever Merger: McCormick announced a $44 billion merger with Unilever's food division, despite being valued at only $14 billion itself, indicating a strategic move to leverage scale and synergies, though past similar deals have often failed to deliver expected value.
  • M&A Activity in Food Sector: The recent surge in mergers within the food industry highlights a market trend towards consolidation and economies of scale, yet historical data suggests that many large consumer brand mergers have not yielded positive outcomes, prompting investors to proceed with caution.
  • Eli Lilly's Centessa Acquisition: Eli Lilly is acquiring Centessa Pharmaceuticals for $7.8 billion, focusing on expediting the market entry of a promising narcolepsy treatment, despite Centessa lacking commercial products, with success hinging on upcoming clinical trial results.
NASDAQ.COM
8.5
04-08NASDAQ.COM
Surge in M&A Activity in the Food Sector
  • Sysco Acquisition Move: Sysco is acquiring Restaurant Depot for $26 billion, aiming to enhance its supply chain efficiency across its network of 700,000 restaurants, thereby solidifying its leadership position in the U.S. food service distribution market.
  • McCormick and Unilever Merger: McCormick announced a merger with Unilever's food division valued at $44 billion, despite McCormick's market cap of only $14 billion, indicating a strategy to leverage scale and resource integration for improved profitability, though it faces integration risks.
  • Market Reactions and Risks: Analysts express caution regarding both Sysco and McCormick's transactions, particularly with Sysco taking on $21 billion in new debt, which could impact its financial stability, while the success of McCormick's merger strategy remains to be seen.
  • Eli Lilly Acquires Centessa: Eli Lilly announced the acquisition of Centessa Pharmaceuticals for $7.8 billion, focusing on rare disease treatments; if FDA approval is secured, it could tap into a $5 billion market, reflecting strong demand and investment willingness in the pharmaceutical sector.
Newsfilter
8.5
04-07Newsfilter
Budweiser Celebrates 40 Years as FIFA World Cup Official Beer Sponsor
  • Limited-Edition Packaging: Budweiser launches the largest limited-edition collectible pack ever, the Budweiser® FIFA World Cup™ Anniversary Pack, featuring 11 designs that pay tribute to every World Cup since 1986, aiming to attract consumers through nostalgia and enhance brand loyalty.
  • Global Film Release: The new global film, 'The Big Drop,' set to the iconic anthem 'You'll Never Walk Alone,' showcases Budweiser bottles traversing continents, emphasizing the brand's deep connection with the World Cup and aiming to elevate brand awareness and market impact through stunning visuals.
  • Digital Interactive Experience: Each limited-edition bottle features a QR code that unlocks exclusive digital content tied to its era, connecting fans to their favorite teams and providing immersive experiences and numerous prizes, further enhancing consumer engagement.
  • Global Outdoor Campaign: Budweiser launches the 'Proudly on the Pitch' global outdoor campaign, utilizing archival imagery to showcase the brand's significant moments in World Cup history, aiming to attract a new generation of fans by revisiting iconic moments and solidifying its position in football culture.
Fool
2.0
04-02Fool
Ambev Shares Dip as Investors Eye Analyst Ratings and Capital Returns
  • Stock Price Movement: Ambev's shares fell by 1.35% today, closing at $2.93, with no specific company catalysts driving the decline, yet investors remain focused on analyst ratings and capital returns for future direction.
  • Surge in Trading Volume: Trading volume reached 42.3 million shares, approximately 71% above the three-month average of 24.7 million shares, indicating increased market interest that could influence future price movements.
  • Board Meeting Outcomes: During the board meeting on March 30, the approval of the 2025 profit allocation plan and suggestions for 2026 salary limits and bylaw amendments were made, alongside a capital increase driven by stock options, which may affect future shareholder returns.
  • Analyst Ratings: As of late March, seven analysts maintained a consensus
NASDAQ.COM
2.0
04-02NASDAQ.COM
Ambev Shares Dip Slightly Amid Analyst Ratings and Capital Returns Focus
  • Stock Performance: Ambev shares closed at $2.93, down 1.35%, with no specific company catalysts driving the decline, yet investors remain focused on analyst ratings and capital returns for future direction.
  • Surge in Trading Volume: Trading volume reached 42.3 million shares today, approximately 71% above the three-month average of 24.7 million shares, indicating increased market interest that could influence future price movements.
  • Analyst Ratings: As of late March, seven analysts maintained a consensus 'hold' rating on Ambev, with an average 12-month price target close to its current level, suggesting limited upside potential unless there is a significant boost in earnings momentum.
  • Board Meeting Impact: During the board meeting on March 30, the approval of 2025 profit allocation and suggested 2026 salary limits was made, although these changes have not improved market sentiment, future changes in stock option compensation will need to be monitored.
Wall Street analysts forecast BUD stock price to rise
2 Analyst Rating
Wall Street analysts forecast BUD stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
75.00
Averages
80.00
High
85.00
Current: 0.000
sliders
Low
75.00
Averages
80.00
High
85.00
TD Cowen
Hold
to
Hold
downgrade
$85 -> $70
AI Analysis
2026-04-20
New
Reason
TD Cowen
Price Target
$85 -> $70
AI Analysis
2026-04-20
New
downgrade
Hold
to
Hold
Reason
TD Cowen lowered the firm's price target on AB InBev to $70 from $85 and keeps a Hold rating on the shares. The firm is "broadly cautious" on large cap staples heading into Q1 earnings. Food companies have yet to show a clear path back to growth, the analyst tells investors in a research note. TD says rising oil costs pose an overhang on the sector. It stays constructive on soft drinks and energy.
TD Cowen
Hold
downgrade
2026-04-20
New
Reason
TD Cowen
Price Target
2026-04-20
New
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on AB InBev to EUR 59 from EUR 72 and keeps a Hold rating on the shares. The firm is "broadly cautious" on large cap staples heading into Q1 earnings. Food companies have yet to show a clear path back to growth, the analyst tells investors in a research note. TD says rising oil costs pose an overhang on the sector. It stays constructive on soft drinks and energy.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BUD
Unlock Now

Valuation Metrics

The current forward P/E ratio for Anheuser-Busch Inbev SA (BUD.N) is 17.64, compared to its 5-year average forward P/E of 16.51. For a more detailed relative valuation and DCF analysis to assess Anheuser-Busch Inbev SA's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
16.51
Current PE
17.64
Overvalued PE
21.75
Undervalued PE
11.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
9.78
Current EV/EBITDA
9.42
Overvalued EV/EBITDA
10.75
Undervalued EV/EBITDA
8.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
2.00
Current PS
2.23
Overvalued PS
2.24
Undervalued PS
1.75

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Find me a trade a d take i
Intellectia · 85 candidates
Region: USVolume: >= -100List Exchange: XNAS, XNYS, XASEMoving Average Relationship: PriceCrossAboveMA20, PriceCrossDownMA20, PriceAboveMA20, PriceAboveMA200, PriceBelowMA20, PriceBelowMA200Is Optionable: TrueSupport Resistance Relationship: PriceBreakResistance, PriceFallBelowSupport, PriceAroundResistance, PriceAroundSupportOne Day Rise Prob: 0 - 100One Day Predict Return: 0.0% - 100.0%One Week Rise Prob: 0 - 100One Week Predict Return: 0.0% - 100.0%Monthly Average Dollar Volume: >= -100Macd: positive, negative, bearish, bullish
Ticker
Name
Market Cap$
top bottom
ABBV logo
ABBV
AbbVie Inc
362.35B
ABT logo
ABT
Abbott Laboratories
182.61B
ARM logo
ARM
Arm Holdings PLC
145.38B
BUD logo
BUD
Anheuser-Busch Inbev SA
133.72B
BTI logo
BTI
British American Tobacco plc
125.56B
ADBE logo
ADBE
Adobe Inc
100.95B
Daily RSI>75 or <25. Price >10.
Intellectia · 336 candidates
Price: >= $10.00Rsi Category: overbought, oversold
Ticker
Name
Market Cap$
top bottom
PG logo
PG
Procter & Gamble Co
382.64B
KO logo
KO
Coca-Cola Co
346.21B
AZN logo
AZN
AstraZeneca PLC
316.36B
NVS logo
NVS
Novartis
315.82B
MCD logo
MCD
McDonald's Corp
237.65B
LIN logo
LIN
Linde PLC
231.01B
Daily RSI above 75 or below 25
Intellectia · 558 candidates
Rsi Category: overbought, oversold
Ticker
Name
Market Cap$
top bottom
PG logo
PG
Procter & Gamble Co
382.64B
KO logo
KO
Coca-Cola Co
346.21B
AZN logo
AZN
AstraZeneca PLC
316.36B
NVS logo
NVS
Novartis
315.82B
MCD logo
MCD
McDonald's Corp
237.65B
LIN logo
LIN
Linde PLC
231.01B
Daily RSI above 75
Intellectia · 300 candidates
Rsi Category: overbought
Ticker
Name
Market Cap$
top bottom
PG logo
PG
Procter & Gamble Co
382.64B
KO logo
KO
Coca-Cola Co
346.21B
AZN logo
AZN
AstraZeneca PLC
316.36B
NVS logo
NVS
Novartis
315.82B
MCD logo
MCD
McDonald's Corp
237.65B
LIN logo
LIN
Linde PLC
231.01B
Daily RSI above 75 RSI divergence
Intellectia · 300 candidates
Rsi Category: overbought
Ticker
Name
Market Cap$
top bottom
PG logo
PG
Procter & Gamble Co
382.64B
KO logo
KO
Coca-Cola Co
346.21B
AZN logo
AZN
AstraZeneca PLC
316.36B
NVS logo
NVS
Novartis
315.82B
MCD logo
MCD
McDonald's Corp
237.65B
LIN logo
LIN
Linde PLC
231.01B
rsi above 80
Intellectia · 365 candidates
Rsi Category: overbought
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
575.54B
ASML logo
ASML
ASML Holding NV
567.84B
JNJ logo
JNJ
Johnson & Johnson
541.85B
MU logo
MU
Micron Technology Inc
439.39B
CVX logo
CVX
Chevron Corp
335.69B
HSBC logo
HSBC
HSBC Holdings PLC
302.10B
Which stocks are making 3 months highs?
Intellectia · 96 candidates
Market Cap: >= 10.00BMarket Cap Category: largeNew High Low: 20_HighQuarter Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
BA logo
BA
Boeing Co
190.08B
AMGN logo
AMGN
Amgen Inc
185.02B
DHR logo
DHR
Danaher Corp
170.97B
GILD logo
GILD
Gilead Sciences Inc
160.18B
Low logo
Low
Lowe's Companies Inc
155.45B
PFE logo
PFE
Pfizer Inc
147.20B
only show stocks under $80
Intellectia · 4414 candidates
Price: <= $80.00
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
KO logo
KO
Coca-Cola Co
309.76B
CSCO logo
CSCO
Cisco Systems Inc
291.16B
NVO logo
NVO
Novo Nordisk A/S
263.42B
INTC logo
INTC
Intel Corp
258.77B
SHEL logo
SHEL
Shell PLC
209.17B
tobacco
Intellectia · 20 candidates
Market Cap: >= 1000.00MBeta: LowRiskWeekly Average Turnover: >= 1,000,000Year Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
309.76B
PM logo
PM
Philip Morris International Inc
262.78B
BUD logo
BUD
Anheuser-Busch Inbev SA
136.12B
BTI logo
BTI
British American Tobacco plc
125.29B
MO logo
MO
Altria Group Inc
102.53B
MNST logo
MNST
Monster Beverage Corp
79.72B
Volume > 1 M, Price > $5, RSI extremes (< 30 or > 70)
Intellectia · 226 candidates
Price: >= $5.00Volume: >= 1,000,000Rsi Category: oversold, overboughtRsi 14: >= 70
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
ASML logo
ASML
ASML Holding NV
526.90B
MU logo
MU
Micron Technology Inc
437.95B
COST logo
COST
Costco Wholesale Corp
436.26B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
LRCX logo
LRCX
Lam Research Corp
286.86B

Whales Holding BUD

H
HANSAINVEST Hanseatische Investment-GmbH
Holding
BUD
+24.62%
3M Return
C
Causeway Capital Management LLC
Holding
BUD
+15.19%
3M Return
M
Macquarie Investment Management Limited
Holding
BUD
+11.48%
3M Return
E
EugÉNie Patri SÉBastien
Holding
BUD
+9.97%
3M Return
S
Stichting Anheuser-Busch InBev
Holding
BUD
+9.97%
3M Return
A
Altria Group, Inc.
Holding
BUD
+9.88%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Anheuser-Busch Inbev SA (BUD) stock price today?

The current price of BUD is 75.295 USD — it has decreased -0.61

What is Anheuser-Busch Inbev SA (BUD)'s business?

Anheuser-Busch Inbev SA is a Belgium-based company. The Company is primarily engaged in the manufacturing of beer. The Company operates through six segments: North America, Middle Americas, South America, EMEA, Asia Pacific, Global Export and Holding companies. The Company's brand portfolio includes global brands, such as Budweiser, Corona and Stella Artois; international brands, including Beck's, Leffe and Hoegaarden, and local champions, such as Bud Light, Skol, Brahma, Antarctica, Quilmes, Victoria, Modelo Especial, Michelob Ultra, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske, Cass and Jupiler. The Company's soft drinks business consists of both own production and agreements with PepsiCo related to bottling and distribution arrangements between its various subsidiaries and PepsiCo. Ambev, which is a subsidiary of the Company, is a PepsiCo bottler. Brands that are distributed under these agreements are Pepsi, 7UP and Gatorade.

What is the price predicton of BUD Stock?

Wall Street analysts forecast BUD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUD is80.00 USD with a low forecast of 75.00 USD and a high forecast of 85.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Anheuser-Busch Inbev SA (BUD)'s revenue for the last quarter?

Anheuser-Busch Inbev SA revenue for the last quarter amounts to 15.56B USD, increased 4.82

What is Anheuser-Busch Inbev SA (BUD)'s earnings per share (EPS) for the last quarter?

Anheuser-Busch Inbev SA. EPS for the last quarter amounts to 0.93 USD, increased 66.07

How many employees does Anheuser-Busch Inbev SA (BUD). have?

Anheuser-Busch Inbev SA (BUD) has 136805 emplpoyees as of April 20 2026.

What is Anheuser-Busch Inbev SA (BUD) market cap?

Today BUD has the market capitalization of 147.79B USD.